Kyntra Bio, Inc.
KYNB· Nasdaq
KYNBKyntra Bio, Inc.
Filed Nov 8, 2016 · 10-Q · 39 days after period end · 0001564590-16-028331
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $30.10M | $19.54M | $13.66M |
| Net Income | -$24.15M | -$45.10M | -$39.54M |
| EPS Diluted | -$0.38 | -$0.74 | -$2.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 8, 2016 · 39 d after period end
